Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor.
Open Access
- 1 July 1994
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 269 (30) , 19256-19261
- https://doi.org/10.1016/s0021-9258(17)32161-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificityNature, 1993
- Activation of bovine endothelial thromboxane receptors triggers release of prostacyclin but not EDRFCardiovascular Research, 1992
- Thromboxane A2 synthesis in pregnancy-induced hypertensionThe Lancet, 1990
- Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.Journal of Clinical Investigation, 1989
- Thromboxane A2: Its generation and role in platelet activationProgress in Lipid Research, 1989
- Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.Journal of Clinical Investigation, 1988
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- ALTERNATIVE SPLICING: A UBIQUITOUS MECHANISM FOR THE GENERATION OF MULTIPLE PROTEIN ISOFORMS FROM SINGLE GENESAnnual Review of Biochemistry, 1987
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- PREVENTION OF PRE-ECLAMPSIA BY EARLY ANTIPLATELET THERAPYThe Lancet, 1985